Market Access Views & Analysis

Views & Analysis

Breaking policy and perceptual barriers: Biosimilars

Experts from Research Partnership analyse the company’s Therapy Watch data to identify how market access policy has impacted the adoption of biosimilars.

Views & Analysis

Teva’s Kim Innes on shaping the post-COVID future with the N...

Like all UK pharma GMs working during the COVID-19 pandemic, Teva’s Kim Innes has found herself leading her company through an unprecedented crisis in one of the worst-hit countries in the

Views & Analysis

Digital health and pharma – adapting to the post-coronavirus...

The need for digital transformation and a response model for coronavirus were among the topics discussed in a recent digital debate

Views & Analysis

Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

Views & Analysis

6 ways to digitise your business at pace

As the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact?

Views & Analysis

Coronavirus pharma news roundup 15/5/20

This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs as studies – and approvals – continued apace.

Breaking policy and perceptual barriers: Biosimilars

Teva’s Kim Innes on shaping the post-COVID future with the N...

Digital health and pharma – adapting to the post-coronavirus...

Deep Dive: Market Access - Breaking Barriers

6 ways to digitise your business at pace

Coronavirus pharma news roundup 15/5/20

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks